Nature Medicine publica los datos del estudio de fase III de Stapokibart para la rinitis alérgica estacional ...Middle East

PR Newswire - News

CHENGDU, China, 7 de abril de 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" o la "Compañía") anunció hoy que la prestigiosa revista médica Nature Medicine ha publicado los resultados del ensayo de fase III de su anticuerpo anti-IL-4Rα, stapokibart, desarrollado...

    Hence then, the article about nature medicine publica los datos del estudio de fase iii de stapokibart para la rinitis alergica estacional was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Nature Medicine publica los datos del estudio de fase III de Stapokibart para la rinitis alérgica estacional )

    Apple Storegoogle play

    Last updated :

    Also on site :